GEN-MKT-18-7897-A
May 27, 2026 | Blogs, Support, Technology, Training | 0 comments
Read time: 2 minutes
Finding the right information shouldn’t slow you down. Whether you’re troubleshooting your mass spec, learning something new, or optimizing performance, access to the right resources at the right moment makes all the difference.
That’s why we’re excited to introduce the SCIEX resource hub, a powerful, centralized destination that brings everything you need together in one seamless experience.
One hub. Endless possibilities.
The new resource hub, fully integrated into the SCIEX Now ecosystem, is more than just a content library. It’s a connected environment where knowledge, tools, and expertise come together to support you at every step of your journey, helping you solve the most impactful analytical challenges in quantitation and characterization.
Instead of searching across different locations, you can now find everything in one place – organized, accessible, and ready when you need it.
What you’ll find inside
The resource hub brings together a comprehensive set of tools and resources to help you move from question to action, faster and with confidence:
A smarter experience, built around you
The more you use the resource hub, the more powerful it becomes.
When you log in, you can:
It’s a smarter, more intuitive way to engage with SCIEX knowledge, designed around how you work.
Why it matters
The resource hub is built to support you wherever you are on your journey:
With everything in one place, you can move faster, smarter, and with greater confidence.
How to access the resource hub
Getting started is simple:
See it for yourself
The best way to experience the resource hub is to explore it firsthand.
Explore the SCIEX resource hub > Log in or create a SCIEX Now account to unlock a personalized experience and keep the resources that matter most right at your fingertips.
Start exploring and transforming how you access knowledge today!
As an analytical strategy, middle-down mass spectrometry (MS) workflows characterize biotherapeutic proteins by analyzing large, digested protein fragments or defined subunits, rather than fully intact proteins (top-down) or digested peptides (bottom-up). A middle-down strategy combines the strengths of top-down and bottom-up approaches by delivering high sequence coverage and structural specificity while maintaining relatively simple sample preparation. In practice, middle-down analysis enables accurate mass measurement, rapid sequence confirmation, and localization of key post-translational modifications (PTMs) on protein subunits that are directly relevant to product quality.
In biopharmaceutical development, sequence variants (SV) are considered an inherent risk of producing complex proteins in living systems. Sequence variants are unintended changes to the amino acid sequence of a biotherapeutic and can be caused by errors in transcription or translation in the host cell, or cell culture and process conditions. Detailed analysis of SVs is important in process and product development to ensure the drug’s safety and efficacy. Even low‑level sequence variants can have significant implications for product quality, safety, and efficacy, making their accurate detection and characterization a critical requirement across development, process optimization, and regulatory submission.
CE‑SDS remains a cornerstone assay for characterizing fragmentation, aggregation, and product‑related impurities in therapeutic proteins. UV detection has been the long‑standing standard. However, it frequently struggles with baseline noise, limited sensitivity for minor fragments, and subjective integration.
Posted by
You must be logged in to post a comment.
Share this post with your network